PAPE, Ulrich-Frank, KASPER, Stefan, MEILER, Johannes, SINN, Marianne, VOGEL, Arndt, MÜLLER, Lothar, BURKHARD, Oswald, CACA, Karel, HEEG, Steffen, BÜCHNER-STEUDEL, Petra, RODRIGUEZ-LAVAL, Victor, KÜHL, Anja Andrea, ARSENIC, Ruza, JANSEN, Holger, TREASURE, Peter und UTKU, Nalân, 2020. Efficacy and safety of CAP7.1 as second-line treatment for advanced biliary tract cancers: data from a randomised phase II study. Freiburg: Universität.

Pape, U.-F., Kasper, S., Meiler, J., Sinn, M., Vogel, A., Müller, L., Burkhard, O., Caca, K., Heeg, S., Büchner-Steudel, P., Rodriguez-Laval, V., Kühl, A.A., Arsenic, R., Jansen, H., Treasure, P., Utku, N., 2020. Efficacy and safety of CAP7.1 as second-line treatment for advanced biliary tract cancers: data from a randomised phase II study. Universität, Freiburg. https://doi.org/10.3390/cancers12113149

Pape, U.-F., Kasper, S., Meiler, J., Sinn, M., Vogel, A., Müller, L., Burkhard, O., Caca, K., Heeg, S., Büchner-Steudel, P., Rodriguez-Laval, V., Kühl, A. A., Arsenic, R., Jansen, H., Treasure, P., & Utku, N. (ca. 2020). Efficacy and safety of CAP7.1 as second-line treatment for advanced biliary tract cancers: data from a randomised phase II study [Cd]. Universität. https://doi.org/10.3390/cancers12113149

Pape U-F, Kasper S, Meiler J, Sinn M, Vogel A, Müller L, Burkhard O, Caca K, Heeg S, Büchner-Steudel P, Rodriguez-Laval V, Kühl AA, Arsenic R, Jansen H, Treasure P, Utku N (2020) Efficacy and safety of CAP7.1 as second-line treatment for advanced biliary tract cancers: data from a randomised phase II study. Universität, Freiburg

Pape, Ulrich-Frank/ Kasper, Stefan/ Meiler, Johannes/ Sinn, Marianne/ Vogel, Arndt/ Müller, Lothar/ Burkhard, Oswald/ Caca, Karel/ Heeg, Steffen/ Büchner-Steudel, Petra/ Rodriguez-Laval, Victor/ Kühl, Anja Andrea/ Arsenic, Ruza/ Jansen, Holger/ Treasure, Peter/ Utku, Nalân, Efficacy and safety of CAP7.1 as second-line treatment for advanced biliary tract cancers: data from a randomised phase II study, Freiburg 2020.